On January 22, 2026, QuidelOrtho released episode 55 of its Science Bytes podcast featuring Michelle Mullens, Global Portfolio Marketing Manager for Transfusion Medicine. Mullens, with over 20 years in blood banking and immunohematology, detailed the dual pressures on today’s blood supply: daily trauma cases and a 15% year-over-year increase in weather-related emergencies. She emphasized the rapid expansion of prehospital low-titer whole blood programs, which has driven O-type unit consumption up by 12% in the past 12 months, and called for precision-targeted donor recruitment to stabilize inventory. Mullens also highlighted the deployment of standardized, high-throughput immunohematology platforms that have reduced manual typing errors by 30% and allowed laboratory teams to focus on complex serological cases, underscoring the critical link between donor diversity, diagnostic reliability and patient safety.

QuidelOrtho announced on January 21, 2026 that it will publish its fourth quarter and full-year 2025 results for the period ending December 28, 2025, after market close on Wednesday, February 11, 2026. The Company will host a live conference call at 2:00 p.m. PT / 5:00 p.m. ET, accessible via webcast on its Investor Relations website or by phone using Conference ID 690468. Management plans to discuss revenue trends in immunoassay and molecular testing platforms, share insights on product adoption rates and outline 2026 guidance. Replay of the webcast will be available in the "Events & Presentations" section of the Investor Relations site, providing investors with on-demand access to commentary on margin performance and capital allocation strategies.